首页> 外国专利> A novel approach for the quantification of drug in low concentration based on the analysis of fluorescent images with voglibose-an antidiabetic drug chosen for the study.

A novel approach for the quantification of drug in low concentration based on the analysis of fluorescent images with voglibose-an antidiabetic drug chosen for the study.

机译:一种基于伏格列波糖(用于研究的抗糖尿病药物)的荧光图像分析,可用于对低浓度药物进行定量的新方法。

摘要

The present invention discloses a novel method for the quantification of drug in low concentration. The quantification of drug in low concentration is based on the analysis of the Fluorescent Images obtained because of Drug Enzyme Interaction as used in Biosensing. Quantification of drugs in low concentration has challenges as their response to regular methods is low and sometimes not detectable. In this invention an anti-diabetic drug -"Voglibose" is used for the study as it is the lowest concentration drug available in the Pharmaceutical Industry. Because of its low concentration, it suffers poor response and requires expensive instrumentation for its analysis. Dissolution, another important parameter for this drug as it is a reactive drug has no method mentioned in the literature and this invention establishes the method for Dissolution Studies. Thus the invention proves a novel approach for the quantification of the drugs and particularly drugs in low concentration.
机译:本发明公开了一种低浓度药物定量的新方法。低浓度药物的定量基于对由于生物传感中使用的药物酶相互作用而获得的荧光图像的分析。低浓度药物的定量分析面临挑战,因为它们对常规方法的反应较低,有时甚至无法检测到。在本发明中,抗糖尿病药物“伏格列波糖”用于研究,因为它是制药工业中可获得的最低浓度的药物。由于其浓度低,因此反应较差,需要昂贵的仪器进行分析。溶出度是该药物的另一个重要参数,因为它是反应性药物,在文献中没有提及方法,并且本发明建立了溶出度研究的方法。因此,本发明证明了用于定量药物特别是低浓度药物的新颖方法。

著录项

  • 公开/公告号IN2015MU04258A

    专利类型

  • 公开/公告日2015-11-20

    原文格式PDF

  • 申请/专利权人

    申请/专利号IN4258/MUM/2015

  • 发明设计人 KULKARNI SHREEDEVI;

    申请日2015-11-09

  • 分类号G01N33;A61K49;

  • 国家 IN

  • 入库时间 2022-08-21 14:24:49

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号